Skip to the beginning of the images gallery

BMS202 (PD-1/PD-L1 inhibitor 2) - ≥98%, high purity , CAS No.1675203-84-5, Agonist of CB 1 receptor;Agonist of CB 2 receptor

Moligand™
≥98%

CAS#: 1675203-84-5
Formula: C₂₅H₂₉N₃O₃
Molecular Weight: 419.5
PubChem CID: 117951478

Item Number

B276435

Grouped product items
SKU	Size	Availability	Price
B276435-1mg	1mg	In stock	$31.90
B276435-5mg	5mg	In stock	$129.90
B276435-10mg	10mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$207.90
B276435-25mg	25mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$430.90
B276435-50mg	50mg	In stock	$757.90
B276435-100mg	100mg	In stock	$1,240.90

A\xa0small-molecule PD-1/PD-L1 interaction inhibitor

View related series

CB1 receptor Agonist CB2 receptor Agonist inhibitor

Basic Description

Synonyms	1675203-84-5\|BMS-202\|PD1-PDL1 inhibitor 2\|PD-1/PD-L1 inhibitor 2\|BMS202\|N-{2-[({2-Methoxy-6-[(2-Methyl[1,1'-Biphenyl]-3-Yl)methoxy]pyridin-3-Yl}methyl)amino]ethyl}acetamide\|CHEMBL4089730\|PD-L1 inhibitor 1\|PD-1/PD-L1 inhibitor 2(BMS-202)\|N-[2-[[2-methoxy-6
Specifications & Purity	≥98%
Storage Temp	Store at -20°C
Shipped In	Ice chest + Ice pads
Grade	Moligand™
Action Type	AGONIST
Mechanism of action	Agonist of CB 1 receptor;Agonist of CB 2 receptor
Product Description	Shipped at 4°C. Store at -20°C.

Associated Targets

CNR1 Tclin Cannabinoid receptor 1 1 Activities

Discover Target: CNR1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CNR2 Tchem Cannabinoid receptor 2 1 Activities

Discover Target: CNR2

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CD274 Tclin Programmed cell death 1 ligand 1 0 Activities

Discover Target: CD274

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Names and Identifiers

IUPAC Name	N-[2-[[2-methoxy-6-[(2-methyl-3-phenylphenyl)methoxy]pyridin-3-yl]methylamino]ethyl]acetamide
INCHI	InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29)
InChi Key	JEDPSOYOYVELLZ-UHFFFAOYSA-N
Canonical SMILES	CC1=C(C=CC=C1C2=CC=CC=C2)COC3=NC(=C(C=C3)CNCCNC(=O)C)OC
Isomeric SMILES	CC1=C(C=CC=C1C2=CC=CC=C2)COC3=NC(=C(C=C3)CNCCNC(=O)C)OC
Alternate CAS	1675203-84-5
PubChem CID	117951478
MeSH Entry Terms	BMS202;N-(2-((2-Methoxy-6-(2-methyl-biphenyl-3-ylmethoxy)-pyridin-3-ylmethyl)-amino)-ethyl)-acetamide;PCC0208025
Molecular Weight	419.5

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

8 results found

Lot Number	Certificate Type	Date	Item
H2217200	Certificate of Analysis	Jun 05, 2023	B276435
H2217201	Certificate of Analysis	Jun 05, 2023	B276435
H2217078	Certificate of Analysis	Jun 05, 2023	B276435
H2111204	Certificate of Analysis	Jun 21, 2022	B276435
H2111205	Certificate of Analysis	Jun 21, 2022	B276435
H2111206	Certificate of Analysis	Jun 21, 2022	B276435
H2111207	Certificate of Analysis	Jun 21, 2022	B276435
H2111099	Certificate of Analysis	Jun 21, 2022	B276435

References

1. Zak KM, Grudnik P, Guzik K, Zieba BJ, Musielak B, Dömling A, Dubin G, Holak TA. (2016) Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).. Oncotarget, 7 (21): (30323-35). [PMID:27083005]
2. Al-Asmakh M et al.. (2021) Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo.. Biomed Pharmacother, 134 (111134). [PMID:33341672]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.